PANC-1 human pancreatic carcinoma cells readily bound and internalized 12I-labeled epidermal growth factor (EGF). Bound 125I-labeled EGF was then partially processed to a number of high molecular weight acidic species. (5), and the gastrointestinal hormone cholecystokinin (6). Further, high concentrations of EGF decrease the number of EGF receptors on the cell surface through a process termed down-regulation (7). We now report an additional mechanism by which some cells may modulate EGF receptor function. In PANC-1 human pancreatic carcinoma cells, internalized EGF is processed mainly to a number of high molecular weight products. Two major products of processed EGF, along with intact EGF, are released into the culture medium. One of these products as well as intact EGF can rebind to the cell surface. These data suggest that in certain cells, recirculation of bindable EGF products may be important in the intracellular disposition of cell-surface EGF receptors.
Epidermal growth factor (EGF) is a protein that regulates numerous cellular functions (1) . Although circulating EGF levels are relatively constant and are not altered under normal physiological conditions (1, 2), a variety of factors in the circulation are known to regulate EGF binding and may conceivably modulate its actions in target cells. Thus, EGF binding is decreased by platelet-derived growth factor (3), ,8-adrenergic agonists (4), the neurohypophyseal hormone vasopressin (5) , and the gastrointestinal hormone cholecystokinin (6) . Further, high concentrations of EGF decrease the number of EGF receptors on the cell surface through a process termed down-regulation (7) .
We now report an additional mechanism by which some cells may modulate EGF receptor function. In PANC-1 human pancreatic carcinoma cells, internalized EGF is processed mainly to a number of high molecular weight products. Two major products of processed EGF, along with intact EGF, are released into the culture medium. One of these products as well as intact EGF can rebind to the cell surface. These data suggest that in certain cells, recirculation of bindable EGF products may be important in the intracellular disposition of cell-surface EGF receptors.
MATERIALS AND METHODS
Cell Culture. PANC-1 human pancreatic carcinoma cells (CRL 1469) were obtained from the American Type Culture Collection. Cells were propagated in monolayer culture at 370C in a 5% C02/95% air atmosphere in Dulbecco's modified Eagle's medium (DMEM) supplemented with antibiotics and 10% newborn calf serum.
Binding Studies. Biologically active EGF was prepared from mouse submaxillary glands by the method of Savage and Cohen (8) . EGF was further purified by reversed-phase HPLC (9) . The most abundant EGF species thus isolated, a-EGF, was iodinated by the chloramine-T method (10) . Labeled EGF was then separated by isoelectric focusing (IEF) into a number of species with different isoelectric points (11 Internalization, Processing, and Degradation Studies. To monitor 125I-labeled EGF internalization, cultured cells were washed as for binding studies and then were incubated for 4 min at 40C with 500 mM NaCl, titrated to pH 2.5 with acetic acid (12) . Radioactivity removed by acid treatment (surfacebound) and acid-resistant (internalized) radioactivity were then determined separately. Internalized ligand was localized with the aid of Percoll gradient fractionation of cell homogenates (11) . Cell disruption was carried out as described (11) , except that homogenization buffer contained 1 mM EDTA, 10 mM acetic acid, and 10 mM triethanolamine at pH 7.4, and was supplemented with 1 mM benzamidine and 0.25 mM phenylmethylsulfonyl fluoride (PMSF) to prevent in vitro proteolysis. Acid phosphatase, UDP-galactosyl transferase, and NADPH-cytochrome c reductase were assayed as reported (11) and served as markers for lysosomes, Golgi apparatus, and endoplasmic reticulum, respectively. To monitor 251I-labeled EGF processing, cell-bound and dissociated radioactivity were analyzed by IEF on horizontal agarose gels using internal standards generated with the aid of pI marker proteins (13) . The locations of 125I-labeled proteins were determined by autoradiography of analytical gels after drying (13) . Degradation of 125I-labeled EGF in incubation medium was monitored by analyzing supernatant radioactivity by Sephadex G-25 column chromatography.
RESULTS
Studies with a highly purified species of EGF (pI 4.55) indicate that, after binding to target cells, the peptide is shortened by the sequential removal of carboxyl-terminal Abbreviations: EGF, epidermal growth factor; IEF, isoelectric focusing.
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amino acids prior to eventual degradation (11, 13 (11) . It was the only species that was still clearly evident at 3 hr into the chase period.
To determine the subcellular distribution of the various molecular species of processed EGF, cell-bound 125I activity was fractionated in 20% (wt/vol) Percoll gradients and the fractions were analyzed by IEF (Fig. 2 ). Immediately after a 15-min pulse, the 125I activity was localized to organelles that appeared in a peak in fraction 11 ( Fig. 2A) . This peak corresponded to a density of 1.04 g/cm3 and coincided with the peaks of cellular UDP-galactosyl transferase, NADPHcytochrome c reductase, and acid phosphatase activities (data not shown). The total recovered 1251 activity decreased gradually during the chase period with unlabeled EGF but continued to be localized in the 1.04 g/cm3 region. The majority of 125I activity in this middle region of the gradient corresponded to the pI 4.2 species of EGF (Fig. 2 Insets, lanes b).
After 15 min of the chase, a lesser peak of 1251 activity was found at a gradient position of higher density (fractions 2-4); this peak was detected at subsequent time points up to 105 min (Fig. 2) . These fractions coincided with a small but reproducible acid phosphatase peak (data not shown). Except at the beginning of the chase ( Fig. 2A) , the majority of 1251 activity in this higher density region (1.08-1.10 g/cm3) corresponded to the extensively processed pI 4.0 species of EGF (Fig. 2, Insets, lanes a) .
To determine whether lysosomotropic compounds can alter the processing of EGF in PANC-1 cells, the effect of methylamine (10 mM) on 125I-labeled EGF radioactivity was examined. During a 30-min pulse, slightly more 1251 activity was bound to methylamine-treated cells than to controls (Fig.   3) . Further, the rate of release of bound 125I activity from methylamine-treated cells during the chase period was -80%o that of controls (Fig. 3A) . The loss of cell-bound 125I activity occurred from both the cell surface (Fig. 3B ) and intracellular sites (Fig. 3C ).
The culture medium from the chase period of this experiment was analyzed by chromatography on Sephadex G-25 and by IEF (Fig. 4) . Ten minutes after initiation of the chase, 125I activity was present only in the void volume (fractions 7-10). The majority of 125I activity in these fractions was distributed between the pI 4.20 and 4.55 species of EGF (Fig.  4A Inset, lane a) . At 3 hr postincubation, the high molecular weight peak increased -3-fold and was associated with the appearance of a small amount of low molecular weight products in fractions 20-30 (Fig. 4A) . Analysis of the high molecular weight peak by IEF indicated that the radioactivity was evenly distributed between the pl 4.55 and 4.20 species (Fig. 4A Inset, lane b) . A significant amount of the pl 4.35 species was also present, whereas the pl 4.0 species was only a minor component. The addition of methylamine prevented the appearance of the low molecular weight metabolites (Fig.  4B ) but did not block the appearance of either the pI 4.35 or 4.20 species of EGF in the culture medium (Fig. 4B Inset, lane  c) . Further, in the presence of methylamine, the preponderant species present in the medium 3 hr after initiation of the chase was the p1 4.2 species (Fig. 4B Inset, lane d) .
To determine whether EGF released from PANC-1 cells could rebind to these cells, a pulse-chase experiment was carried out in which the chase was performed in either the presence or the absence of unlabeled EGF. Radioactivity released into the incubation medium was then analyzed by Sephadex G-25 chromatography. Ten minutes after initiation of the chase in the absence of unlabeled EGF, there was a 60% reduction in the amount of 125I present in the void volume peak in comparison with the corresponding peak observed when the chase occurred in the presence of a large excess of unlabeled EGF (Fig. SA) . The size of this peak increased during the subsequent 2 hr only when unlabeled EGF was present in the incubation medium (Fig. 5B) . However, the amount of low molecular weight radioactivity present at 2 hr was similar under both incubation conditions. pI values are at right. DISCUSSION The first step in the action of EGF is represented by its binding to a specific cell-surface glycoprotein receptor (14) .
The binding process leads to receptor activation and internalization and to the generation of signals that ultimately mediate the effects of EGF (15) . In most cells the majority of internalized EGF is then transported to lysosomes and is subsequently degraded (12) . In the present study, we have determined that EGF is not readily degraded in PANC-1 human pancreatic carcinoma cells. As in Rat-1 fibroblasts (11), EGF was processed in PANC-1 cells to a number of high molecular weight moieties. However, the major product of processed EGF in Rat-1 fibroblasts is the pI 4.0 moiety (11) . In contrast, the major product of processed EGF in PANC-1 cells was the pI 4.20 species, which localized mainly to organelles in the middle region of the Percol gradients. This species was readily released from these organelles and was extruded ultimately into the incubation medium.
A portion of bound EGF was also converted to the more highly processed pI 4.0 species. This moiety slowly accumulated within the cell in organelles that localized mainly to a Proc. Natl. Acad Sci. USA 82 (1985) Proc. Natl. Acad. Sci. USA 82 (1985) high density position on Percoll gradients. Only a small amount ofthe pI 4.0 species of EGF was released directly into the incubation medium. Further, its disappearance from cell homogenates was associated with the appearance of low molecular weight degradation products. Taken together with previous studies of the precursor-product relationship of EGF processing (11, 16) , these observations suggest that EGF degradation in PANC-1 cells is dependent on its prior processing to the pI 4.0 species.
The ability of methylamine to block the degradation of EGF to low molecular weight products suggests that this degradation occurred within cellular organelles that have an acidic internal milieu (17) . Methylamine also increased the amount ofthe pI 4.2 species of EGF in the incubation medium but decreased the amounts of the pI 4.55 and 4.35 derivatives.
Because the generation and extrusion of the pI 4.2 species of EGF were not blocked by methylamine, it is likely that this species is formed in a distinct, nonacidic compartment in PANC-1 cells.
Three lines of evidence in the present study indicate that EGF is recycled between the intracellular compartments and the incubation medium. First, internalized 1251I-labeled EGF was readily released from PANC-1 cells into the incubation medium, and the majority of this radioactivity consisted of intact or slightly processed EGF. Second, the preponderant species of processed EGF that was released into the incubation medium (pI 4.2) is able to bind to the EGF receptor with at least the same affinity as intact EGF (11) . Third, in the absence of competing unlabeled EGF during pulse-chase experiments (Fig. 5) , there was a marked decrease in the amount of high molecular weight products in incubation medium without a concomitant increase of low molecular weight degradation products. This decrease was therefore most likely due to the rebinding of dissociated EGF and its pI 4.2 derivative.
It is generally accepted that after receptor-mediated endocytosis, polypeptide ligands dissociate from their receptors in acidic intracellular organelles before being degraded (18) . Our data indicate that PANC-1 cells are not deficient in acidic organelles. Further, PANC-1 cells bind and readily degrade insulin-like growth factor I (19) . It is therefore unlikely that these cells have a nonspecific defect that interferes with the degradation ofpolypeptide growth factors. Although the mechanism that allows EGF to be released from PANC-1 cells into the incubation medium is not clear, the recycling of EGF by these cells indicates that a single molecule of the growth factor is able to induce the internalization of more than one EGF receptor. The release of EGF and its bindable products may therefore represent an additional mechanism that can potentially modulate the activation and disposition of the cell-surface EGF receptor. The precise nature of the molecular signals generated by this recycling remains to be determined.
